SWOG clinical trial number
CTSU/CALGB 140503
A Phase III Randomized Trial Of Lobectomy Versus Sublobar Resection For Small (Less Than Or Equal To 2 cm) Peripheral Non-Small Cell Lung Cancer
Closed
Abbreviated Title
Phase III Randomized Lobectomy vs Sublobar Resection in Small Peripheral NSCLC
Status Notes
This study is permanently closed for all initial registrations effective Friday, March 13, 2017 at 4:30 p.m. EST.
Activated
01/15/2008
Closed
03/13/2017
Participants
CTSU
Research committees
Lung Cancer
Treatment
Surgery
Eligibility Criteria Expand/Collapse
The Southwest Oncology Group has endorsed this study through the Cancer Trials Support Unit (CTSU) of the National Cancer Institute.
Please contact the CTSU directly by either phone (1-888-823-5923) or on the CTSU web site (http://www.ctsu.org/) for more information and registration procedures.
Please contact the CTSU directly by either phone (1-888-823-5923) or on the CTSU web site (http://www.ctsu.org/) for more information and registration procedures.
Other Clinical Trials
SWOG Clinical Trial Number
CTSU/EA5231
A Randomized Phase III Trial of Checkpoint Blockade in Lung Cance3r Patients in the Adjuvant Setting Based on Pathologic Response Following Neoadjuvant Therapy (CLEAR)
Research Committee(s)
Lung Cancer
Activated
06/13/2025
Open
SWOG Clinical Trial Number
S2414
INcorporating pathologic reSponse in patIents with early staGe lung cancer to optimize immunotHerapy in the adjuvanT setting (INSIGHT)
Research Committee(s)
Lung Cancer
Symptom Control and Quality of Life
Activated
03/14/2025
Accrual
2%
Open
Phase
SWOG Clinical Trial Number
CTSU/A082304/S2402
Perioperative Versus Adjuvant Systemic Therapy In Patients with Resectable Non-Small Cell Lung Cancer - PROSPECT LUNG, CTIU2317
Research Committee(s)
Lung Cancer
Activated
12/11/2024
Open